Ivf Asia Group selects HubSpot Ads for Digital Advertising Platform

In 2022, Ivf Asia Group, a Philippines based Healthcare organization with 10 employees and revenues of $1M selected HubSpot Ads for Digital Advertising Platform while displacing Legacy, and integrating with the existing systems being used.

Customer Vendor Old Product New Product Category Market Users VAR/SI When Live
Ivf Asia Group HubSpot Legacy HubSpot Ads Digital Advertising Platform CRM n/a n/a 2022 2022
Discover the latest software purchases and digital transformation initiatives being undertaken by Ivf Asia Group and its business and technology executives by accessing the entire Ivf Asia Group and its business and technology executives by becoming a Premium Subscriber. On a continuous basis, our research team identifies and updates the on-prem and cloud applications that are being used by Ivf Asia Group employees from publicly available data (Press Releases, Customer References, Case Studies, Success Stories, Testimonials, RFP, RFI, etc.) as well as proprietary sources, and incorporate them into the customer profile.

Don't miss the entire: Ivf Asia Group Technographics profile

FAQ - Ivf Asia Group selects HubSpot Ads for (Digital Advertising Platform)

In 2022, Ivf Asia Group selected HubSpot Ads for Digital Advertising Platform to modernize their CRM operations and improve scalability, visibility, and control.

The HubSpot Ads deployment replaces Legacy and integrates with existing systems to streamline processes, reporting, and compliance across CRM.

Ivf Asia Group is a Healthcare organization in Philippines, with approximately 10 employees and $1M in annual revenue.

Ivf Asia Group has initiated the HubSpot Ads implementation with an expected go-live in 2022, supporting its modernization of Digital Advertising Platform processes.

Ivf Asia Group has not disclosed the SI for the HubSpot Ads implementation.

Subscribe to APPS RUN THE WORLD to view the verified software purchases, implementation timelines, and related deployments.